Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician

Jana De Brandt,1 Rosanne JHCG Beijers,2 Joe Chiles,3 Matthew Maddocks,4 Merry-Lynn N McDonald,3 Annemie MWJ Schols,2 André Nyberg1 1Faculty of Medicine, Department of Community Medicine and Rehabilitation, Section of Physiotherapy, Umeå University, Umeå, Sweden; 2Department of Respiratory Medicine,...

Full description

Bibliographic Details
Main Authors: De Brandt J, Beijers RJHCG, Chiles J, Maddocks M, McDonald MLN, Schols AMWJ, Nyberg A
Format: Article
Language:English
Published: Dove Medical Press 2022-11-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/update-on-the-etiology-assessment-and-management-of-copd-cachexia-cons-peer-reviewed-fulltext-article-COPD
_version_ 1811186960255942656
author De Brandt J
Beijers RJHCG
Chiles J
Maddocks M
McDonald MLN
Schols AMWJ
Nyberg A
author_facet De Brandt J
Beijers RJHCG
Chiles J
Maddocks M
McDonald MLN
Schols AMWJ
Nyberg A
author_sort De Brandt J
collection DOAJ
description Jana De Brandt,1 Rosanne JHCG Beijers,2 Joe Chiles,3 Matthew Maddocks,4 Merry-Lynn N McDonald,3 Annemie MWJ Schols,2 André Nyberg1 1Faculty of Medicine, Department of Community Medicine and Rehabilitation, Section of Physiotherapy, Umeå University, Umeå, Sweden; 2Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, the Netherlands; 3Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; 4Cicely Saunders Institute of Palliative Care, Policy and Rehabilitation, King’s College London, London, UKCorrespondence: Jana De Brandt, Section of Physiotherapy, Department of Community Medicine and Rehabilitation, Faculty of Medicine, Umeå University, Umeå, 901 87, Sweden, Tel +32 477 73 98 11, Email jana.de.brandt@umu.seAbstract: Cachexia is a commonly observed but frequently neglected extra-pulmonary manifestation in patients with chronic obstructive pulmonary disease (COPD). Cachexia is a multifactorial syndrome characterized by severe loss of body weight, muscle, and fat, as well as increased protein catabolism. COPD cachexia places a high burden on patients (eg, increased mortality risk and disease burden, reduced exercise capacity and quality of life) and the healthcare system (eg, increased number, length, and cost of hospitalizations). The etiology of COPD cachexia involves a complex interplay of non-modifiable and modifiable factors (eg, smoking, hypoxemia, hypercapnia, physical inactivity, energy imbalance, and exacerbations). Addressing these modifiable factors is needed to prevent and treat COPD cachexia. Oral nutritional supplementation combined with exercise training should be the primary multimodal treatment approach. Adding a pharmacological agent might be considered in some, but not all, patients with COPD cachexia. Clinicians and researchers should use longitudinal measures (eg, weight loss, muscle mass loss) instead of cross-sectional measures (eg, low body mass index or fat-free mass index) where possible to evaluate patients with COPD cachexia. Lastly, in future research, more detailed phenotyping of cachectic patients to enable a better comparison of included patients between studies, prospective longitudinal studies, and more focus on the impact of exacerbations and the role of biomarkers in COPD cachexia, are highly recommended.Keywords: chronic obstructive pulmonary disease, muscle, weight loss, nutrition, pulmonary rehabilitation
first_indexed 2024-04-11T13:55:08Z
format Article
id doaj.art-904094eca7c14da3a0f4f8f63338d529
institution Directory Open Access Journal
issn 1178-2005
language English
last_indexed 2024-04-11T13:55:08Z
publishDate 2022-11-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-904094eca7c14da3a0f4f8f63338d5292022-12-22T04:20:23ZengDove Medical PressInternational Journal of COPD1178-20052022-11-01Volume 172957297679752Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the ClinicianDe Brandt JBeijers RJHCGChiles JMaddocks MMcDonald MLNSchols AMWJNyberg AJana De Brandt,1 Rosanne JHCG Beijers,2 Joe Chiles,3 Matthew Maddocks,4 Merry-Lynn N McDonald,3 Annemie MWJ Schols,2 André Nyberg1 1Faculty of Medicine, Department of Community Medicine and Rehabilitation, Section of Physiotherapy, Umeå University, Umeå, Sweden; 2Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, the Netherlands; 3Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; 4Cicely Saunders Institute of Palliative Care, Policy and Rehabilitation, King’s College London, London, UKCorrespondence: Jana De Brandt, Section of Physiotherapy, Department of Community Medicine and Rehabilitation, Faculty of Medicine, Umeå University, Umeå, 901 87, Sweden, Tel +32 477 73 98 11, Email jana.de.brandt@umu.seAbstract: Cachexia is a commonly observed but frequently neglected extra-pulmonary manifestation in patients with chronic obstructive pulmonary disease (COPD). Cachexia is a multifactorial syndrome characterized by severe loss of body weight, muscle, and fat, as well as increased protein catabolism. COPD cachexia places a high burden on patients (eg, increased mortality risk and disease burden, reduced exercise capacity and quality of life) and the healthcare system (eg, increased number, length, and cost of hospitalizations). The etiology of COPD cachexia involves a complex interplay of non-modifiable and modifiable factors (eg, smoking, hypoxemia, hypercapnia, physical inactivity, energy imbalance, and exacerbations). Addressing these modifiable factors is needed to prevent and treat COPD cachexia. Oral nutritional supplementation combined with exercise training should be the primary multimodal treatment approach. Adding a pharmacological agent might be considered in some, but not all, patients with COPD cachexia. Clinicians and researchers should use longitudinal measures (eg, weight loss, muscle mass loss) instead of cross-sectional measures (eg, low body mass index or fat-free mass index) where possible to evaluate patients with COPD cachexia. Lastly, in future research, more detailed phenotyping of cachectic patients to enable a better comparison of included patients between studies, prospective longitudinal studies, and more focus on the impact of exacerbations and the role of biomarkers in COPD cachexia, are highly recommended.Keywords: chronic obstructive pulmonary disease, muscle, weight loss, nutrition, pulmonary rehabilitationhttps://www.dovepress.com/update-on-the-etiology-assessment-and-management-of-copd-cachexia-cons-peer-reviewed-fulltext-article-COPDchronic obstructive pulmonary diseasemuscleweight lossnutritionpulmonary rehabilitation
spellingShingle De Brandt J
Beijers RJHCG
Chiles J
Maddocks M
McDonald MLN
Schols AMWJ
Nyberg A
Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician
International Journal of COPD
chronic obstructive pulmonary disease
muscle
weight loss
nutrition
pulmonary rehabilitation
title Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician
title_full Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician
title_fullStr Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician
title_full_unstemmed Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician
title_short Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician
title_sort update on the etiology assessment and management of copd cachexia considerations for the clinician
topic chronic obstructive pulmonary disease
muscle
weight loss
nutrition
pulmonary rehabilitation
url https://www.dovepress.com/update-on-the-etiology-assessment-and-management-of-copd-cachexia-cons-peer-reviewed-fulltext-article-COPD
work_keys_str_mv AT debrandtj updateontheetiologyassessmentandmanagementofcopdcachexiaconsiderationsfortheclinician
AT beijersrjhcg updateontheetiologyassessmentandmanagementofcopdcachexiaconsiderationsfortheclinician
AT chilesj updateontheetiologyassessmentandmanagementofcopdcachexiaconsiderationsfortheclinician
AT maddocksm updateontheetiologyassessmentandmanagementofcopdcachexiaconsiderationsfortheclinician
AT mcdonaldmln updateontheetiologyassessmentandmanagementofcopdcachexiaconsiderationsfortheclinician
AT scholsamwj updateontheetiologyassessmentandmanagementofcopdcachexiaconsiderationsfortheclinician
AT nyberga updateontheetiologyassessmentandmanagementofcopdcachexiaconsiderationsfortheclinician